Document is current
Any future updates will be listed below
-
Authors
Wang, M
Sun, J
Crosby, A
Woodard, K
Hirsch, M L
Samulski, R J
Li, C
- License Information
-
More Information
Article History
Received: 1 September 2016
Revised: 25 October 2016
Accepted: 2 November 2016
First Online: 11 November 2016
Competing interests
: R Jude Samulski is the founder and a shareholder at Asklepios BioPharmaceutical. He receives research support through the University of North Carolina from Asklepios BioPharmaceutical. He holds patents that have been licensed by UNC to Asklepios Biopharmaceutical, for which he receives royalties. He has consulted for Baxter Healthcare and has received payment for speaking. All other authors declare no conflict of interest.
